138 related articles for article (PubMed ID: 7691835)
1. Investigation of the ability of several naturally occurring and synthetic polyanions to bind to and potentiate the biological activity of acidic fibroblast growth factor.
Belford DA; Hendry IA; Parish CR
J Cell Physiol; 1993 Oct; 157(1):184-9. PubMed ID: 7691835
[TBL] [Abstract][Full Text] [Related]
2. Sulfated glycosaminoglycans modify growth factor-induced neurite outgrowth in PC12 cells.
Damon DH; D'Amore PA; Wagner JA
J Cell Physiol; 1988 May; 135(2):293-300. PubMed ID: 2967302
[TBL] [Abstract][Full Text] [Related]
3. Evidence that carboxyl-reduced heparin fails to potentiate acidic fibroblast growth factor activity due to an inability to interact with cell surface heparin receptors.
Brown KJ; Hendry IA; Parish CR
Exp Cell Res; 1995 Mar; 217(1):132-9. PubMed ID: 7532589
[TBL] [Abstract][Full Text] [Related]
4. Stabilization by heparin of acidic fibroblast growth factor mitogenicity for human endothelial cells in vitro.
Mueller SN; Thomas KA; Di Salvo J; Levine EM
J Cell Physiol; 1989 Sep; 140(3):439-48. PubMed ID: 2777882
[TBL] [Abstract][Full Text] [Related]
5. Heparin-derived oligosaccharides: affinity for acidic fibroblast growth factor and effect on its growth-promoting activity for human endothelial cells.
Bârzu T; Lormeau JC; Petitou M; Michelson S; Choay J
J Cell Physiol; 1989 Sep; 140(3):538-48. PubMed ID: 2550475
[TBL] [Abstract][Full Text] [Related]
6. Heparin modulation of the neurotropic effects of acidic and basic fibroblast growth factors and nerve growth factor on PC12 cells.
Neufeld G; Gospodarowicz D; Dodge L; Fujii DK
J Cell Physiol; 1987 Apr; 131(1):131-40. PubMed ID: 3032991
[TBL] [Abstract][Full Text] [Related]
7. Structure-function studies of heparin-binding (acidic fibroblast) growth factor-1 using site-directed mutagenesis.
Burgess WH; Shaheen AM; Hampton B; Donohue PJ; Winkles JA
J Cell Biochem; 1991 Feb; 45(2):131-8. PubMed ID: 1711526
[TBL] [Abstract][Full Text] [Related]
8. Biological studies of a putative avian muscle-derived neurotrophic factor that prevents naturally occurring motoneuron death in vivo.
Oppenheim RW; Prevette D; Haverkamp LJ; Houenou L; Yin QW; McManaman J
J Neurobiol; 1993 Aug; 24(8):1065-79. PubMed ID: 8409968
[TBL] [Abstract][Full Text] [Related]
9. Heparin-dependent fibroblast growth factor activities: effects of defined heparin oligosaccharides.
Zhou FY; Kan M; Owens RT; McKeehan WL; Thompson JA; Linhardt RJ; Höök M
Eur J Cell Biol; 1997 May; 73(1):71-80. PubMed ID: 9174673
[TBL] [Abstract][Full Text] [Related]
10. Physical stabilization of acidic fibroblast growth factor by polyanions.
Volkin DB; Tsai PK; Dabora JM; Gress JO; Burke CJ; Linhardt RJ; Middaugh CR
Arch Biochem Biophys; 1993 Jan; 300(1):30-41. PubMed ID: 7678726
[TBL] [Abstract][Full Text] [Related]
11. Heparin potentiates the action of acidic fibroblast growth factor by prolonging its biological half-life.
Damon DH; Lobb RR; D'Amore PA; Wagner JA
J Cell Physiol; 1989 Feb; 138(2):221-6. PubMed ID: 2465300
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of a heparin antagonist (hexadimethrine) or chlorate on amphiregulin, basic fibroblast growth factor, and heparin-binding EGF-like growth factor activity.
Cook PW; Ashton NM; Karkaria CE; Siess DC; Shipley GD
J Cell Physiol; 1995 May; 163(2):418-29. PubMed ID: 7706383
[TBL] [Abstract][Full Text] [Related]
13. Biological and binding studies of acidic fibroblast growth factor in the presence of substituted dextran.
Tardieu M; Slaoui F; Josefonvicz J; Courty J; Gamby C; Barritault D
J Biomater Sci Polym Ed; 1989; 1(1):63-70. PubMed ID: 2484952
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional structure of acidic fibroblast growth factor in solution: effects of binding to a heparin functional analog.
Pineda-Lucena A; Jiménez MA; Lozano RM; Nieto JL; Santoro J; Rico M; Giménez-Gallego G
J Mol Biol; 1996 Nov; 264(1):162-78. PubMed ID: 8950275
[TBL] [Abstract][Full Text] [Related]
15. Derivatized dextrans mimic heparin as stabilizers, potentiators, and protectors of acidic or basic FGF.
Tardieu M; Gamby C; Avramoglou T; Jozefonvicz J; Barritault D
J Cell Physiol; 1992 Jan; 150(1):194-203. PubMed ID: 1370503
[TBL] [Abstract][Full Text] [Related]
16. Mitogenic activity of acidic fibroblast growth factor is enhanced by highly sulfated oligosaccharides derived from heparin and heparan sulfate.
Gambarini AG; Miyamoto CA; Lima GA; Nader HB; Dietrich CP
Mol Cell Biochem; 1993 Jul; 124(2):121-9. PubMed ID: 7694075
[TBL] [Abstract][Full Text] [Related]
17. Probing the affinity of polyanions for acidic fibroblast growth factor by unfolding kinetics.
Mach H; Middaugh CR
Arch Biochem Biophys; 1994 Feb; 309(1):36-42. PubMed ID: 7509590
[TBL] [Abstract][Full Text] [Related]
18. Ability of different chemically modified heparins to potentiate the biological activity of heparin-binding growth factor 1: lack of correlation with growth factor binding.
Belford DA; Hendry IA; Parish CR
Biochemistry; 1992 Jul; 31(28):6498-503. PubMed ID: 1378755
[TBL] [Abstract][Full Text] [Related]
19. Importance of size, sulfation, and anticoagulant activity in the potentiation of acidic fibroblast growth factor by heparin.
Sudhalter J; Folkman J; Svahn CM; Bergendal K; D'Amore PA
J Biol Chem; 1989 Apr; 264(12):6892-7. PubMed ID: 2708348
[TBL] [Abstract][Full Text] [Related]
20. In vitro changes in plasma membrane heparan sulfate proteoglycans and in perlecan expression participate in the regulation of fibroblast growth factor 2 mitogenic activity.
Guillonneau X; Tassin J; Berrou E; Bryckaert M; Courtois Y; Mascarelli F
J Cell Physiol; 1996 Jan; 166(1):170-87. PubMed ID: 8557766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
